<table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="tbl1" position="float"><object-id pub-id-type="doi">10.7554/eLife.04114.018</object-id><label>Table 1.</label><caption><p>Cytoplasmic and nuclear subviral complexes in MDM</p><p><bold>DOI:</bold> <ext-link ext-link-type="doi" xlink:href="10.7554/eLife.04114.018">http://dx.doi.org/10.7554/eLife.04114.018</ext-link></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2"/><th colspan="3">Cytoplasm</th><th colspan="3">Nucleus</th><th rowspan="2">Proportion of nuclear complexes [%]</th><th rowspan="2">Number of cells imaged</th></tr><tr><th>RTC/PIC (n)</th><th>CA-positive RTC/PIC (n)</th><th>CA-positive RTC/PIC [%]</th><th>PIC (n)</th><th>CA-positive PIC (n)</th><th>CA-positive PIC [%]</th></tr></thead><tbody><tr><td><bold>24 hr</bold></td><td>90</td><td>46</td><td><bold>51</bold></td><td>9</td><td>9</td><td><bold>100</bold></td><td>9</td><td>367</td></tr><tr><td><bold>48 hr</bold></td><td>45</td><td>13</td><td><bold>29</bold></td><td>61</td><td>59</td><td><bold>97</bold></td><td>58</td><td>200</td></tr><tr><td><bold>Total</bold></td><td>135</td><td>59</td><td><bold>44</bold></td><td>70</td><td>68</td><td><bold>97</bold></td><td>34</td><td>567</td></tr></tbody></table><table-wrap-foot><fn><p>The table summarizes data from primary MDM infected with NL4-3-R5(IN.eGFP) or NL4-3-4059(IN.eGFP) for 24 hr or 48 hr, respectively. Infected MDM were immunostained with antibodies against nuclear pore complexes and CA. Data were obtained as outlined in <xref ref-type="fig" rid="fig7">Figure 7</xref> in cells from eight different donors in five independent experiments (cells from three donors were infected for both 24 hr and 48 hr).</p></fn></table-wrap-foot></table-wrap>